Aarti Pharmalabs Ltd.

The quarter ended December 2023 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 3730.30 millions.The company has announced a 25.04% increase in its profits to Rs . 481.90  millions for the  quarter ended December 2023 compared to Rs. 385.40 millions in the corresponding quarter in the previous year.Operating profit for the quarter ended December 2023 rose to 884.80 millions as compared to 726.00 millions of corresponding quarter ended December 2022.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202312	202212	% Var	202312	202212	% Var	202303	202203	% Var
Sales	3730.30	3593.30	3.81	10873.10	11369.80	-4.37	15112.50	9410.20	60.60
Other Income	2.00	0.40	400.00	50.60	12.80	295.31	12.80	25.10	-49.00
PBIDT	884.80	726.00	21.87	2438.80	2328.10	4.75	3096.20	1822.90	69.85
Interest	41.00	51.20	-19.92	119.50	146.90	-18.65	204.90	113.40	80.69
PBDT	843.80	674.80	25.04	2319.30	2181.20	6.33	2891.30	1709.50	69.13
Depreciation	169.40	145.60	16.35	487.00	415.20	17.29	557.70	372.30	49.80
PBT	674.40	529.20	27.44	1832.30	1766.00	3.75	2333.60	1337.20	74.51
TAX	192.50	143.80	33.87	456.00	448.80	1.60	616.30	270.00	128.26
Deferred Tax	62.50	22.50	177.78	112.50	67.50	66.67	95.00	45.00	111.11
PAT	481.90	385.40	25.04	1376.30	1317.20	4.49	1717.30	1067.20	60.92
Equity	453.10	453.10	0.00	453.10	453.10	0.00	453.10	455.60	-0.55
PBIDTM(%)	23.72	20.20	17.40	22.43	20.48	9.54	20.49	19.37	5.76